Onc.AI Revenue and Competitors

Location

#6049

Growjo Ranking

Estimated Revenue & Valuation

  • Onc.AI's estimated annual revenue is currently $4.5M per year.(i)
  • Onc.AI's estimated revenue per employee is $112,000

Employee Data

  • Onc.AI has 40 Employees.(i)
  • Onc.AI grew their employee count by 21% last year.

Onc.AI's People

NameTitleEmail/Phone
1
CEO, FounderReveal Email/Phone
2
CTO, Founding Team MemberReveal Email/Phone
3
VP AI/ML & Chief Software ArchitectReveal Email/Phone
4
VP Software, FounderReveal Email/Phone
5
Head PeopleReveal Email/Phone
6
VP Data Partnerships & OperationsReveal Email/Phone
7
Head ProductReveal Email/Phone
8
Manager, Data OperationsReveal Email/Phone
9
Project ManagerReveal Email/Phone
10
Member Board DirectorsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$14.1M1015%N/AN/A
#2
$1.6M19-71%N/AN/A
#3
$212.8M10635%$65MN/A
#4
$6.8M548%N/AN/A
#5
$12.9M922%$23.1MN/A
#6
$1M12N/AN/AN/A
#7
$106.5M599-17%$2.3MN/A
#8
$35.6M2316%N/AN/A
#9
$38.3M2495%N/AN/A
#10
$45M299-4%$102.6MN/A
Add Company

What Is Onc.AI?

Oncology, AI, genomics, proteomics, radiomics, ML, diagnostics

keywords:N/A

N/A

Total Funding

40

Number of Employees

$4.5M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Onc.AI News

2022-04-20 - Targeted Treatment Arsenal for Myelofibrosis Set to Explode

During a recent OncLive Peer Exchange®, a panel of hematology cancer experts discussed currently approved and emerging JAK inhibitors as well as...

2022-04-19 - U.S. Hem/Onc Pharms Teach, and Learn, in Nigeria

Although she has met several Nigerian healthcare professionals and students as a clinical pharmacy professor at the University of Colorado...

2022-04-17 - ONC Chief Lists Security as His Biggest Current Challenge

A federal interagency group is looking at equity issues raised by artificial intelligence. Micky Tripathi, PhD, MPP, took the helm of the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M40-31%N/A
#2
N/A4029%N/A
#3
$4.8M403%N/A
#4
$10.3M400%N/A
#5
$8.6M40-33%N/A